Clinical trial
Triple Negative Breast Cancer Biomarker Study
NCT01111175
Study timeline
Study start (unknown)2010-05-01Date precision: month
Registry last updated2013-07-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Breast Cancerunresolved
Triple Negative Breast Cancerunresolved
Interventions
Sponsors & collaborators
US Oncology Researchlead sponsor
Translational Drug Developmentcollaborator
Life Technologies, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01111175 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.